Record NNP B-NP O
date NN I-NP O
: : O O
2081-03-30 CD O B-DATE
Asked VBN B-VP O
by IN B-PP O
Dr NNP B-NP O
Dunn NNP I-NP B-DOCTOR
and CC O O
Dr. NNP B-NP O
Needham NNP I-NP B-DOCTOR
to TO B-VP O
comment VB I-VP O
on IN B-PP O
DM NNP B-NP O
management NN I-NP O
in IN B-PP O
this DT B-NP O
58 CD I-NP B-AGE
y/o JJ I-NP O
man NN I-NP O
admited VBD B-VP O
for IN B-PP O
amputation NN B-NP O
site NN I-NP O
debridement NN I-NP O
. . O O
He PRP B-NP O
had VBD B-VP O
fem-pop JJ B-NP O
in IN B-PP O
2080 CD B-NP B-DATE
, , O O
and CC O O
a DT B-NP O
R NN I-NP O
toe NN I-NP O
amp NN I-NP O
in IN B-PP O
9/8 CD B-NP I-DATE
0 CD I-NP I-DATE
. . O O
Howevere RB B-ADVP O
the DT B-NP O
site NN I-NP O
never RB B-VP O
healed VBN I-VP O
, , O O
despite IN B-PP O
lack NN B-NP O
of IN B-PP O
clear JJ B-NP O
infection NN I-NP O
. . O O
He PRP B-NP O
is VBZ B-VP O
readmited VBN I-VP O
on IN B-PP O
3/28 CD B-NP B-DATE
for IN B-PP O
debridement NN B-NP O
. . O O
Narrative JJ B-NP O
History NN I-NP O
Type NN B-NP O
2 CD I-NP O
DM NNP I-NP O
diagnosed VBD B-VP O
in IN B-PP O
2078 CD B-NP B-DATE
- : O O
presented VBN B-VP O
with IN B-PP O
urinary JJ B-NP O
frequency NN I-NP O
and CC O O
was VBD B-VP O
not RB I-VP O
feeling VBG I-VP O
well RB B-ADVP O
. . O O
He PRP B-NP O
was VBD B-VP O
admitted VBN I-VP O
to TO B-PP O
the DT B-NP O
hospital NN I-NP O
for IN B-PP O
BG NNP B-NP O
's POS B-NP O
of IN B-PP O
400 CD B-NP O
's POS B-NP O
and CC O O
discharged VBD B-VP O
on IN B-PP O
NPH NNP B-NP O
insulin NN I-NP O
30 CD B-NP O
units NNS I-NP O
q JJ B-NP O
am VBP I-NP O
and CC O O
15 CD B-NP O
units NNS I-NP O
q RB B-ADVP O
pm VBP B-VP O
. . O O
He PRP B-NP O
has VBZ B-VP O
followed VBN I-VP O
up RP B-PRT O
with IN B-PP O
Dr. NNP B-NP O
Dunn NNP I-NP B-DOCTOR
from IN B-PP O
our PRP$ B-NP O
Diabetes NNP I-NP O
department NN I-NP O
. . O O
He PRP B-NP O
has VBZ B-VP O
not RB I-VP O
seen VBN I-VP O
her PRP B-NP O
since IN B-PP O
3/8 CD B-NP I-DATE
0 CD I-NP I-DATE
but CC O O
has VBZ B-VP O
kept VBN I-VP O
up RP B-PRT O
with IN B-PP O
her PRP$ B-NP O
by IN B-PP O
phone NN B-NP O
. . O O
His PRP$ B-NP O
home NN I-NP O
DM IN B-PP O
regimen NNP B-NP O
consists VBZ B-NP O
of IN B-PP O
NPH NNP B-NP O
insulin NN I-NP O
25 CD B-NP O
units NNS I-NP O
q RB B-ADVP O
am VBP B-VP O
and CC O O
10 CD B-NP O
units NNS I-NP O
q RB B-ADVP O
hs VBD B-VP O
. . B-NP O
Last JJ I-NP O
A1c NNP I-NP O
was VBD B-VP O
6.1 CD B-NP O
3/8 CD I-NP I-DATE
0 CD I-NP I-DATE
and CC O O
his PRP$ B-NP O
BG NNP I-NP O
's POS B-NP O
run NN I-NP O
~ IN B-PP O
100 CD B-NP O
. . O O
He PRP B-NP O
has VBZ B-VP O
hypoglycemia NN B-NP O
unawareness NN I-NP O
. . O O
He PRP B-NP O
has VBZ B-VP O
PVD VBN I-VP O
s/p RB B-ADJP O
fem-fem JJ I-ADJP O
bypass IN B-PP O
graft NN B-VP O
6/30/8 CD B-NP I-DATE
0 CD I-NP I-DATE
, , O O
ulcer NN B-NP O
on IN B-PP O
R NN B-NP O
big JJ I-NP O
toe NN I-NP O
, , O O
( -LRB- B-NP O
+)peripheral JJ I-NP O
neuropathy NN I-NP O
. . O O
Past NNP B-NP O
Medical NNP I-NP O
History NNP I-NP O
Morbidly RB B-ADJP O
obese JJ I-ADJP O
, , O O
+ JJ B-NP O
sleep NN I-NP O
apnea NN I-NP O
, , O O
+BPH NNP B-NP O
, , O O
h/o RB B-NP O
gastric JJ I-NP O
reflux NN I-NP O
, , O O
h/o VBD B-VP O
pseudotumor NN B-NP O
cerebri NN I-NP O
, , O O
s/p VBD B-VP O
hip NN B-NP O
surgery NN I-NP O
Family NNP B-NP O
History NN I-NP O
no DT B-NP O
diabetes NNS I-NP O
Social NNP B-NP O
History NNP I-NP O
Smoking NNP B-NP O
( -LRB- I-NP O
+ NN I-NP O
) -RRB- O O
Medications NNS B-NP O
Text NNP I-NP O
Meds NNS B-NP O
now RB B-ADVP O
: : O O
NPH NNP B-NP O
insulin NN I-NP O
25 CD B-NP O
units NNS I-NP O
q RB B-ADVP O
am VBP B-VP O
and CC O O
10 CD B-NP O
units NNS I-NP O
q RB B-ADVP O
hs NNS B-NP O
regular JJ B-NP O
insulin NN I-NP O
SS NNP B-NP O
if IN B-PP O
BG NNP B-NP O
> VBD B-VP O
125 CD O O
simvastatin NN B-NP O
lasix NN B-NP O
lisinopril NN B-NP O
ECASA NNP B-NP O
esomeprazole NN B-NP O
atenolol NN B-NP O
SC NNP B-NP O
heparin NN I-NP O
Folate NN B-NP O
Ancef NNP B-NP O
1 CD I-NP O
gm NN I-NP O
Q8H . O O
Physical NNP B-NP O
Exam NNP I-NP O
BP NNP B-NP O
140/73 CD I-NP O
Pulse NNP B-NP O
48 CD I-NP O
reg NN I-NP O
T NNP B-NP O
98.7 CD I-NP O
General NNP B-NP O
Appearance NNP I-NP O
morbidly RB B-ADVP O
obese NN O O
pleasant JJ B-NP O
and CC I-NP O
talkative JJ I-NP O
HEENT NN B-NP O
anicteric JJ B-NP O
sclerae NNS I-NP O
Neck NN B-NP O
trachea NN B-NP O
midline NN I-NP O
Chest NNP B-NP O
CTA . O O
Cor/Cardiac NNP B-NP O
RRR NN B-NP O
Abdomen . O O
Soft NNP B-NP O
, , O O
obese NN B-NP O
Extremity NN B-NP O
dressing VBG B-VP O
intact JJ B-ADJP O
on IN B-PP O
ulcer NN B-NP O
, , O O
R NN B-NP O
foot NN I-NP O
Neurological JJ O O
alert JJ B-ADJP O
, , O O
oriented VBN O O
Skin NNP B-NP O
( -LRB- B-NP O
+ NN I-NP O
) -RRB- I-NP O
acanthosis NN I-NP O
nigracans NNS I-NP O
Laboratory NNP B-NP O
Data NNPS I-NP O
A1c JJ B-NP O
6.1 CD I-NP O
in IN B-PP O
3/8 CD B-NP I-DATE
0 CD I-NP I-DATE
FS NNS B-NP O
's POS B-NP O
49 CD I-NP O
on IN B-PP O
admission NN B-NP O
( -LRB- I-NP O
no DT I-NP O
sx NN I-NP O
) -RRB- O O
104 CD B-NP O
94 CD I-NP O
132 CD I-NP O
65 CD O O
92 CD B-NP O
95 CD I-NP O
LFT NNP B-NP O
wnl NN I-NP O
Creat NNP B-NP O
1.3 CD I-NP O
Assessment NN B-NP O
Type NN B-NP O
2 CD I-NP O
DM NNP I-NP O
complicated VBN B-VP O
by IN B-PP O
PVD NNP B-NP O
and CC I-NP O
neuropathy NN I-NP O
. . O O
Well RB B-VP O
controlled VBN I-VP O
on IN B-PP O
his PRP$ B-NP O
home NN I-NP O
regimen NNS I-NP O
. . O O
Recommendation NN B-NP O
1 CD B-NP O
. . O O
Continue NNP B-NP O
NPH NNP I-NP O
insulin NN I-NP O
25 CD B-NP O
units NNS I-NP O
q RB B-ADVP O
am VBP B-VP O
and CC O O
10 CD B-NP O
units NNS I-NP O
q RB B-ADVP O
hs NNS B-VP O
. . O O
2. DT B-NP O
Suggest NNP I-NP O
to TO B-VP O
change VB I-VP O
regular JJ B-NP O
insulin NN I-NP O
sliding VBG I-NP O
scale NN I-NP O
to TO B-VP O
humalog VB I-VP O
as IN B-PP O
this DT B-NP O
is VBZ B-VP O
more JJR B-NP O
physiologic NN I-NP O
( -LRB- I-NP O
acts NNS B-VP O
faster RBR B-ADVP O
and CC O O
clears VBZ B-VP O
faster RBR B-ADVP O
as RB I-ADVP O
well RB I-ADVP O
) -RRB- O O
. . B-VP O
Give VB I-VP O
only RB B-NP O
half DT I-NP O
doses NNS I-NP O
of IN B-PP O
this DT B-NP O
at IN B-PP O
hs NNS B-NP O
since IN B-SBAR O
he PRP B-NP O
will MD B-VP O
not RB I-VP O
be VB I-VP O
eating VBG I-VP O
then RB B-ADVP O
. . O O
3. `` O O
Please VB B-VP O
get VB I-VP O
a DT B-NP O
Hemoglobin NNP I-NP O
A1c NNP I-NP O
. . O O
This DT B-NP O
will MD B-VP O
help VB I-VP O
us PRP B-NP O
assess VB B-VP O
blood NN B-NP O
glucose NN I-NP O
control NN I-NP O
for IN B-PP O
the DT B-NP O
past JJ I-NP O
2-3 CD I-NP O
months NNS I-NP O
and CC O O
can MD B-VP O
help VB I-VP O
in IN B-PP O
discharge NN B-NP O
planning NN I-NP O
. . O O
4 LS O O
. . O O
He PRP B-NP O
should MD B-VP O
folow-up VB I-VP O
with IN B-PP O
Dr. NNP B-NP O
Dunn NNP I-NP B-DOCTOR
from IN B-PP O
Diabetes NNP B-NP O
. . O O
Thank VB B-VP O
you PRP B-NP O
. . O O
Barbara NNP B-NP B-DOCTOR
Ely NNP I-NP I-DOCTOR
MD . O O
